Inventor
STRAUSS LAURA
US2 patents
Patents
2 patentsUS12258409B2Mar 25, 2025
Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies
DANA FARBER CANCER INST INC0 citations54
US11492403B2Nov 8, 2022
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof
DANA FARBER CANCER INST INC1 citations54